National publications highlight UC stroke research
A number of national news publications highlighted research presented by the University of Cincinnati's Eva Mistry, MBBS, at the International Stroke Conference 2023.
Mistry presented the results of the BEST-II trial, which found using blood pressure medications to lower the top number of blood pressure readings (systolic blood pressure) may not be safe or effective among people who have an acute ischemic stroke and undergo a successful mechanical clot removal.
"This line of inquiry is probably not worth pursuing," Mistry, assistant professor in the Department of Neurology and Rehabilitation medicine in UC’s College of Medicine and a UC Health physician at the UC Gardner Neuroscience Institute, told Medscape. "If lowering blood pressure improves outcomes, that improvement is fairly marginal, and there are trends that suggest that, in fact, it might be harmful."
Read the Neurology Live article.
Read more about Mistry's research.
Featured photo at top of Dr. Mistry with a patient. Photo/Andrew Higley/UC Marketing + Brand.
Related Stories
WLWT: UC hosts RESET epilepsy trial
May 3, 2023
WLWT spoke with the University of Cincinnati's Brandon Foreman about a clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.
U.S. News: Scientists propose new mechanism driving Alzheimer's
October 6, 2022
U.S. News & World Report highlighted recent research from the University of Cincinnati that supports the hypothesis that Alzheimer’s disease is caused by a decline in levels of a protein called amyloid-beta.
National publications highlight UC stroke research
February 13, 2023
Several national news outlets highlighted the University of Cincinnati's Eva Mistry presenting on the results of the BEST-II trial at the International Stroke Conference.